We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan · Delayed Price · Currency is TWD 22.50
-0.30 (-1.32%)
Jul 9, 2026, 1:30 PM CST
We Can Medicines Market Cap
We Can Medicines has a market cap or net worth of 1.01 billion as of July 9, 2026. Its market cap has decreased by -33.26% in one year.
Market Cap
1.01B
Enterprise Value
2.00B
Revenue
3.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
22.50
Market Cap Chart
Since December 9, 2022, We Can Medicines's market cap has decreased from 1.84B to 1.01B, a decrease of -44.87%. That is a compound annual growth rate of -15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.01B | -34.46% |
| Dec 31, 2025 | 1.55B | -10.72% |
| Dec 31, 2024 | 1.73B | -59.87% |
| Dec 29, 2023 | 4.32B | 13.80% |
| Dec 30, 2022 | 3.80B | 106.30% |
| Dec 9, 2022 | 1.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fwusow Industry | 4.20B |
| SunWay Biotech Co., LTD. | 3.71B |
| Eagle Cold Storage Enterprise | 3.40B |
| Ten Ren Tea | 2.58B |
| Hantech Bio-Technology | 2.16B |
| Wonder Pets Enterprises | 2.15B |
| Tai Roun Products | 2.09B |
| Far East Bio-Tec | 1.52B |